[
  {
    "ts": null,
    "headline": "Amgen Inc. stock underperforms Wednesday when compared to competitors",
    "summary": "Amgen Inc. stock underperforms Wednesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=edbff0a24f18c65b5f23e12c22ee027fe8c2f8064a3837532a4cfa8f12ae7b44",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734539940,
      "headline": "Amgen Inc. stock underperforms Wednesday when compared to competitors",
      "id": 132066871,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Amgen Inc. stock underperforms Wednesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=edbff0a24f18c65b5f23e12c22ee027fe8c2f8064a3837532a4cfa8f12ae7b44"
    }
  },
  {
    "ts": null,
    "headline": "Viridian Therapeutics: Veligrotug De-Risked In TED With Hints Of Differentiation",
    "summary": "Viridian's veligrotug shows promising results in treating TED patients, setting the stage for future growth in the biopharmaceutical company. Read more here.",
    "url": "https://finnhub.io/api/news?id=53a707effab74db195b8f76c7bd18a3bdf2d4ef5cf930ec983759d9bc87a71fc",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734519362,
      "headline": "Viridian Therapeutics: Veligrotug De-Risked In TED With Hints Of Differentiation",
      "id": 132039547,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1464160868/image_1464160868.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Viridian's veligrotug shows promising results in treating TED patients, setting the stage for future growth in the biopharmaceutical company. Read more here.",
      "url": "https://finnhub.io/api/news?id=53a707effab74db195b8f76c7bd18a3bdf2d4ef5cf930ec983759d9bc87a71fc"
    }
  }
]